A comparison of cardiac 31P MRS at 1.5 and 3 T

NMR in Biomedicine

Volumn 21, Issue 8, 2008, Pages 793-798

  Tyler, Damian J ^a,b   Hudsmith, Lucy E ^a   Clarke, Kieran ^b   Neubauer, Stefan ^a   Robson, Matthew D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiac energetics; Field strength; MRS; Phosphorus

Indexed keywords

CARDIAC ENERGETICS; FIELD STRENGTH; MRS; PHOSPHORUS;

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; GAMMA ADENOSINE TRIPHOSPHATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GEOMETRY; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIATION FIELD; RADIOFREQUENCY; RELAXATION TIME; SIGNAL NOISE RATIO;

ADENOSINE TRIPHOSPHATE; ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIUM; PHOSPHOCREATINE; PHOSPHORUS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 53849120978     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1255     Document Type: Article

References (21)

1. Neubauer S, Horn M, Hahn D, Kochsiek KT. Clinical cardiac magnetic resonance spectroscopy: present state and future directions. Mol. Cell. Biochem. 1998; 184(1-2): 439-443.
2. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C, Mader H, Kromer EP, Riegger GAJ, Lackner K, Ertl G. P-31 magnetic-resonance spectroscopy in dilated cardiomyopathy and coronary-artery disease - altered cardiac high-energy phosphate-metabolism in heart-failure. Circulation 1992; 86(6): 1810-1818.
3. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003; 107(24): 3040-3046.
4. Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P, McKenna WJ, Ostman-Smith I, Clarke K, Watkins H. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. Journal Of The American College Of Cardiology 2003; 41(10): 1776-1782.
5. Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by P-31 magnetic-resonance spectroscopy. Lancet 1991; 338(8773): 973-976.
6. Conway MA, Bottomley PA, Ouwerkerk R, Radda GK, Rajagopalan B. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 1998; 97(17): 1716-1723.
7. Neubauer S, Horn M, Pabst T, Harre K, Stromer H, Bertsch G, Sandstede J, Ertl G, Hahn D, Kochsiek K. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by P-31-magnetic resonance spectroscopy. Journal Of Investigative Medicine 1997; 45(8): 453-462.
8. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96(7): 2190-2196.
9. Bottomley PA, Hardy CJ, Weiss RG. Correcting human heart P-31 NMR-spectra for partial saturation - evidence that saturation factors for PCr ATP are homogeneous in normal and disease states. Journal Of Magnetic Resonance 1991; 95(2): 341-355.
10. Hetherington HP, Luney DJE, Vaughan JT, Pan JW, Ponder SL, Tschendel O, Twieg DB, Pohost GM. 3d P-31 Spectroscopic imaging of the human heart at 4.1-T. Magnetic Resonance In Medicine 1995; 33(3): 427-431.
11. Menon RS, Hendrich K, Hu XP, Ugurbil K. P-31 NMR-spectroscopy of the human heart at 4-T: detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium. Magnetic Resonance In Medicine 1992; 26(2): 368-376.
12. Bottomley PA, Ouwerkerk R. The dual-angle method for fast, Sensitive T-1 measurement in-vivo with low-angle adiabatic pulses. Journal Of Magnetic Resonance Series B 1994; 104(2): 159-167.
13. Staewen RS, Johnson AJ, Ross BD, Parrish T, Merkle H, Garwood M. 3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Investigative Radiology 1990; 25(5): 559-567.
14. Bottomley PA, Ouwerkerk R. BIRP, an improved implementation of low-angle adiabatic (BIR-4) excitation pulses. Journal Of Magnetic Resonance Series A 1993; 103(2): 242-244.
15. Naressi A, Couturier C, Castang I, de Beer R, Uraveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Computers In Biology And Medicine 2001; 31(4): 269-286.
16. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. Magnetic Resonance Materials In Physics Biology And Medicine 2001; 12(2-3): 141-152.
17. Bottomley PA, Ouwerkerk R. Optimum flip-angles for exciting NMR with uncertain T-1 values. Magnetic Resonance In Medicine 1994; 32(1): 137-141.
18. Ernst RR, Bodenhausen G, Wokaun A. Principles of Nuclear Magnetic Resonance in One and Two Dimensions. Oxford University Press: Oxford, 2004; 148-151.
19. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed 2001; 14(4): 278-283.
20. Hardy CJ, Bottomley PA, Rohling KW, Roemer PB. An NMR phased-array for human cardiac P-31 spectroscopy. Magnetic Resonance In Medicine 1992; 28(1): 54-64.
21. Lee RF, Giaquinto R, Constantinides C, Souza S, Weiss RG, Bottomley PA. A broadband phased-array system for direct phosphorus and sodium metabolic MRI on a clinical scanner. Magnetic Resonance In Medicine 2000; 43(2): 269-277.